Outsourcing global clinical
& medical engagement for accelerated drug approval
& acceptance
In an exclusive Reuters Pharma USA 2025 interview, Brian O’Donnell, President of Contract Sales Teams at Amplity, shared how outsourced teams in pharma are driving innovation and reshaping the industry. According to O’Donnell, outsourcing is helping pharmaceutical companies save costs, enter the market faster, and access specialized talent in areas like oncology and rare diseases. Beyond that, outsourced teams are enabling companies to stay agile, scale quickly, and navigate the complexities of a highly regulated environment—all essential for success in today’s fast-moving market.
So, why is outsourcing becoming a go-to strategy for pharma leaders? Let’s break down the five ways outsourced teams are creating value and attracting top talent.
As O’Donnell pointed out, outsourced teams in pharma are so much more than a cost-saving measure—they’re a strategic advantage. They help companies move faster, stay agile, and attract top talent while keeping everything compliant.
In today’s competitive market, outsourcing isn’t just a nice-to-have—it’s a game-changer. Whether it’s cutting costs, speeding up launches, or navigating complex regulations, outsourced teams are proving to be a critical part of the commercial playbook for the future of pharma.
Ready to rethink your strategy? Outsourcing might just be the answer. Watch the video now to hear more.
If you’re curious about how outsourcing can help pharma companies thrive in today’s fast-paced market, hit play and discover the top 5 ways it’s transforming the industry.
Visit Amplity Sales and Amplity Medical to better understand how our expert-led outsourced teams drive value—from launch to landing.